InnovaRx Innova Health Strategies

J84.89

Other specified interstitial pulmonary diseases

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 18 never code together
J84.89code
Excludes1
  • cryptogenic organizing pneumonia (J84.116)J84.116
  • idiopathic non-specific interstitial pneumonitis (J84.113)J84.113
  • lipoid pneumonia, exogenous or unspecified (J69.1)J69.1
  • lymphoid interstitial pneumonia (J84.2)J84.2
J84.8code
Excludes1
  • exogenous lipoid pneumonia (J69.1)J69.1
  • unspecified lipoid pneumonia (J69.1)J69.1
J84code
Excludes1
  • drug-induced interstitial lung disorders (J70.2-J70.4)J70.2-J70.4
  • interstitial emphysema (J98.2)J98.2
Excludes2
  • lung diseases due to external agents (J60-J70)J60-J70
J00-J99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • smoke inhalation (T59.81-)T59.81-
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 17
J84code
Code also
  • , if applicable, associated condition
J84.89code
Inclusion terms
  • Endogenous lipoid pneumonia
  • Interstitial pneumonitis
  • Non-specific interstitial pneumonitis NOS
  • Organizing pneumonia NOS
Code first
  • , if applicable:
  • poisoning due to drug or toxin (T51-T65 with fifth or sixth character to indicate intent), for toxic pneumonopathyT51-T65
  • underlying cause of pneumonopathy, if known
Use additional code
  • code, for adverse effect, to identify drug (T36-T50 with fifth or sixth character 5), if drug-inducedT36-T50
J00-J99chapter
Notes
  • When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).J40
Use additional code
  • code, where applicable, to identify:
  • exposure to environmental tobacco smoke (Z77.22)Z77.22
  • exposure to tobacco smoke in the perinatal period (P96.81)P96.81
  • history of tobacco dependence (Z87.891)Z87.891
  • occupational exposure to environmental tobacco smoke (Z57.31)Z57.31
  • tobacco dependence (F17.-)F17.-
  • tobacco use (Z72.0)Z72.0
Index entries leading here 5
  • BOOP (bronchiolitis obliterans organized pneumonia) J84.89
  • Bronchiolitis (acute) (infective) (subacute) J21.9
  • Pneumonia (acute) (double) (migratory) (purulent) (septic) (unresolved) J18.9
    • bronchiolitis obliterans organized (BOOP) J84.89
    • broncho-, bronchial (confluent) (croupous) (diffuse) (disseminated) (hemorrhagic) (involving lobes) (lobar) (terminal) J18.0
    • cholesterol J84.89
    • lipid, lipoid (exogenous) J69.1
    • interstitial J84.9
    • organizing J84.89
  • Pneumonitis (acute) (primary) J98.4
  • Disease, diseased — see also Syndrome
Alongside this code 4 same parent — J84.8
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC112 CMS28HCC280 ESRD21HCC112 ESRD24HCC112 RX08HCC227

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
J84.8
Block
J80-J84
Siblings
4

Present FY2024–FY2027.